In keeping with our prior survey, we found that pediatric medulloblastomas and ependymomas exhibited minimal CD73 expression, while numerous high- and low-grade gliomas, gangliogliomas, and a subset of craniopharyngiomas exhibited high CD73 levels (Fig. 5F). This evidence concerns the gene NT5E and medulloblastoma.